G1 Therapeutics Inc (GTHX)
4.49
+0.05
(+1.13%)
USD |
NASDAQ |
May 03, 16:00
4.58
+0.09
(+2.00%)
After-Hours: 20:00
G1 Therapeutics Cash from Financing (Quarterly): 0.034M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.034M |
| September 30, 2023 | 0.022M |
| June 30, 2023 | -26.75M |
| March 31, 2023 | -0.214M |
| December 31, 2022 | 52.35M |
| September 30, 2022 | 0.127M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.018M |
| December 31, 2021 | 43.76M |
| September 30, 2021 | 2.083M |
| June 30, 2021 | 1.481M |
| March 31, 2021 | 98.54M |
| December 31, 2020 | 0.472M |
| September 30, 2020 | 0.284M |
| June 30, 2020 | 20.71M |
| March 31, 2020 | 0.219M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.386M |
| September 30, 2019 | 1.372M |
| June 30, 2019 | 0.678M |
| March 31, 2019 | 0.269M |
| December 31, 2018 | 0.105M |
| September 30, 2018 | 219.52M |
| June 30, 2018 | 12.11M |
| March 31, 2018 | 108.76M |
| December 31, 2017 | 0.202M |
| September 30, 2017 | -0.303M |
| June 30, 2017 | 107.71M |
| March 31, 2017 | -0.285M |
| December 31, 2016 | 0.002M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 49.76M |
| March 31, 2016 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-26.75M
Minimum
Jun 2023
98.54M
Maximum
Mar 2021
10.29M
Average
0.386M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 8.21M |
| Geron Corp | 147.80M |
| Palatin Technologies Inc | 4.974M |
| Oragenics Inc | -0.1806M |
| TG Therapeutics Inc | -0.001M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.79M |
| Cash from Investing (Quarterly) | -7.647M |
| Free Cash Flow | -38.34M |
| Free Cash Flow Per Share (Quarterly) | -0.2468 |
| Free Cash Flow to Equity (Quarterly) | -13.10M |
| Free Cash Flow to Firm (Quarterly) | -11.05M |
| Free Cash Flow Yield | -15.79% |